Corient Private Wealth’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62M Buy
12,654
+2,981
+31% +$1.12M 0.01% 937
2026
Q1
$2.72M Buy
9,673
+325
+3% +$94.3K ﹤0.01% 1102
2025
Q4
$2.76M Buy
9,348
+1,308
+16% +$394K ﹤0.01% 1000
2025
Q3
$1.98M Sell
8,040
-7,075
-47% -$1.43M ﹤0.01% 1067
2025
Q2
$2.36M Buy
15,115
+6,718
+80% +$714K ﹤0.01% 965
2025
Q1
$662K Buy
8,397
+247
+3% +$26.2K ﹤0.01% 1464
2024
Q4
$752K Buy
8,150
+650
+9% +$50.8K ﹤0.01% 1435
2024
Q3
$383K Sell
7,500
-50
-0.7% -$2.58K ﹤0.01% 1886
2024
Q2
$433K Buy
7,550
+50
+0.7% +$2.52K ﹤0.01% 1723
2024
Q1
$337K Hold
7,500
﹤0.01% 1830
2023
Q4
$220K Sell
7,500
-10,956
-59% -$291K ﹤0.01% 2025
2023
Q3
$443K Sell
18,456
-2,784
-13% -$57K ﹤0.01% 1561
2023
Q2
$307K Buy
21,240
+37
+0.2% +$458 ﹤0.01% 1685
2023
Q1
$274K Sell
21,203
-452
-2% -$5.78K ﹤0.01% 1654
2022
Q4
$245K Buy
+21,655
New +$228K ﹤0.01% 1412

Other funds holding CLS

Corient Private Wealth's CLS Position: Q2 2026 in Review

Corient Private Wealth increased its Celestica (CLS) stake by 31% in Q2 2026, buying an estimated $1.12M and bringing the position to 12,654 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #937.

Corient Private Wealth first reported a position in CLS in Q4 2022 and has held it in 15 quarters since. 878 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Corient Private Wealth held 12,654 shares of Celestica worth $4.62M as of Q2 2026.
  • Corient Private Wealth bought 2,981 Celestica shares in Q2 2026, an estimated $1.12M.
  • Celestica made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #937 holding.
  • Corient Private Wealth first reported a position in Celestica in Q4 2022 and has held it in 15 quarters since.
  • 878 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.